Sara Bromlow

Sara Bromlow is a Validation Engineer at Iovance Biotherapeutics, Inc. since October 2022, responsible for authoring and approving Validation Engineering lifecycle documents for Tumor Infiltrating Lymphocyte (TIL) therapy manufacturing and QC analytical systems. Prior to this role, Sara served as a CQV Engineer at DPS Group Global from July 2018 to October 2022, where responsibilities included developing validation documentation and qualifying QC and manufacturing equipment. Sara holds a Bachelor of Engineering degree in Biomedical Engineering from the University of Delaware, earned between 2013 and 2017.